Steven Gore, MD

Acting Branch Chief

Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale. He joined the Investigational Drug Branch at CTEP in 2020.

Dr. Gore is an internationally recognized expert in drug development in leukemia. His research career focused on the development of drugs with epigenetic targets for the treatment of myeloid disease, and he has played a major role in the incorporation of epigenetic modifiers in the treatment of myeloid malignancies. Among his many other accomplishments, Dr. Gore served on the NCI Leukemia Steering Committee beginning in 2015 and served as co-chair from 2017 until he joined CTEP. Dr. Gore is author or co-author of over 200 scholarly publications including primary research papers, book chapters, books, reviews, and practice guidelines.